FOI release

Freedom of Information request on graphene oxide in COVID-19 vaccinations (FOI 21/1035)

Published 17 January 2022

13th September 2021

FOI 21/1035

Dear

Thank you for your enquiry. To answer Question 2. Companies must disclose all excipients as is detailed in the Human Medicines Regulations 2012, this legislation also provides the foundation of our response to Q.1—a company would be in breach of regulations if they were to include a ‘hidden’ excipient. In addition, Official Medicines Control Laboratory (OMCL) batch release is a legal requirement for vaccines and blood products. This is independent testing for every batch that is intended to be marketed.

The below articles may also be of interest to you.

Fact Check-COVID-19 vaccines do not contain graphene oxide - Reuters

Pfizer vaccine does not contain graphene oxide (apnews.com)

Given the above, please confirm if you are happy for us to rescind your request for an internal review in relation to FOI 21/1001.

If you have a query about the information provided, please reply to this email

If you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date you receive this response and addressed to: [email protected]

Due to the ongoing Covid-19 situation, we are not able to accept delivery of any documents or correspondence by post or courier to any of our offices

Please remember to quote the reference number above in any future communications.

If you were to remain dissatisfied with the outcome of the internal review, you would have the right to apply directly to the Information Commissioner for a decision. Please bear in mind that the Information Commissioner will not normally review our handling of your request unless you have first contacted us to conduct an internal review. The Information Commissioner can be contacted at:

Information Commissioner’s Office

Wycliffe House
Water Lane
Wilmslow
Cheshire
SK9 5AF

Yours sincerely

MHRA Customer Service Centre